Tourmaline Bio, Inc.

TRML

Tourmaline Bio, Inc.

TRML

Insider Sentiment (TTM):

Last Purchase:2024-08-21Last Sale:2023-06-14Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2025-09-30Institutional Shares Owned:21,398,842Shares Outstanding:25,755,000Institutional Ownership Pct.:83.09%

Earnings Market Reaction:

Filing Date:N/APrice on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30
Assets
Cash And Cash Equivalents At Carrying Value	31	35	31	35	70	98	141	78	87	4	8	18
Marketable Securities Current	-	-	-	-	-	-	-	80	134	142	168	175
Assets Current
Assets Current	249	258	269	294	298	300	209	151	156	169	8	198
Available For Sale Securities Debt Securities Curr…	208	214	228	247	219	195	62	-	-	-	0	-
Prepaid Expense And Other Assets Current	10	9	11	12	9	7	6	4	4	3	0	4
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	3	0	5
Assets Held In Trust Noncurrent	-	-	-	-	-	-	-	0	2	-	-	-
Available For Sale Securities Debt Securities Nonc…	17	26	37	32	45	57	0	-	-	-	-	-
Restricted Cash Noncurrent	0	0	0	0	0	0	0	-	-	-	0	-
Operating Lease Right Of Use Asset	0	0	0	0	0	0	0	0	1	1	0	3
Restricted Cash	-	-	-	-	-	-	-	-	0	-	-	-
Other Assets Noncurrent	3	3	3	2	1	1	1	0	0	0	0	0
Assets	269	287	309	328	345	359	210	151	159	173	9	207
Liabilities And Stockhold…
Accounts Payable Current	3	2	4	2	2	2	1	0	3	3	0	2
Accrued Liabilities Current	7	5	5	5	4	3	4	7	6	6	1	6
Liabilities Current
Liabilities Current	10	8	9	7	6	5	5	8	10	10	1	9
Operating Lease Liability Current	0	0	0	0	0	0	0	1	1	1	0	1
Other Liabilities Current	-	-	-	-	-	-	-	0	0	-	-	-
Operating Lease Liability Noncurrent	0	0	0	0	0	0	0	0	0	1	0	2
Other Liabilities Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities	10	8	9	7	7	5	5	8	11	11	2	12
Temporary Equity Carrying Amount Attributable To P…	-	-	-	-	-	-	0	-	-	-	27	-
Preferred Stock Value	0	0	0	0	0	0	0	-	-	-	0	-
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Convertible Preferred Sto…
Stockholders Equity
Stockholders Equity	259	280	300	321	338	354	205	-47	-43	-27	-20	195
Additional Paid In Capital	440	438	435	433	432	430	267	352	351	349	0	342
Accumulated Other Comprehensive Income Loss Net Of…	0	0	0	1	-0	-0	0	-0	-0	-0	0	-1
Retained Earnings Accumulated Deficit	-181	-158	-135	-113	-93	-75	-62	-209	-202	-187	-20	-146
Liabilities And Stockholders Equity	269	287	309	328	345	359	210	151	159	173	9	207
Nonvoting Common Stock	0	10	10	0	0	10	10	0	0	10	10	0
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	-	-	-	0	-
Temporary Equity Par Or Stated Value Per Share	-	-	-	-	-	-	0	-	-	-	0	-
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	-	-	-	0	-
Temporary Equity Shares Issued	-	-	-	-	-	-	0	-	-	-	27	-
Temporary Equity Shares Authorized	-	-	-	-	-	-	0	-	-	-	27	-
Temporary Equity Shares Outstanding	-	-	-	-	-	-	0	-	-	-	27	-
Preferred Stock Shares Issued	0	0	0	0	0	0	0	-	-	-	0	-
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	-	-	-	0	-
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	140	140	140	140	140	140	140	140	140	140	50	140
Common Stock Shares Issued	26	26	26	26	26	26	20	20	4	4	1	4
Shares Outstanding	26	26	26	26	26	26	20	20	4	4	1	4

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

No price variance data available.

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30
Liquidity Ratios
Current Ratio	24.68	33.87	30.18	40.33	46.87	62.17	41.76	18.64	15.41	16.59	6.10	21.61
Quick Ratio	23.70	32.71	28.99	38.70	45.52	60.71	40.57	18.14	15.02	16.29	6.06	21.15
Working Capital	239.01M	250.52M	259.93M	286.50M	291.77M	295.27M	203.87M	142.94M	146.07M	158.68M	6.95M	188.96M
Leverage & Debt
Debt to Equity	0.04	0.03	0.03	0.02	0.02	0.01	0.03	-0.17	-0.25	-0.41	-0.09	0.06
Interest Coverage TTM	-	-	-	-	-31.83	-15.06	-8.63	0.98	-1.24	-2.19	-7.63	-49.57
Debt Ratio	0.04	0.03	0.03	0.02	0.02	0.01	0.02	0.05	0.07	0.06	0.19	0.06
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-3.44	-3.23	-2.89	-2.53	-1.97	-1.99	-8.87	7.23	-5.64	-9.87	-22.46	-16.82
Free Cash Flow Per Share TTM	-3.35	-3.27	-3.05	-2.55	-1.85	-1.63	-5.93	17.57	10.79	2.06	-13.61	-14.69
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	74.57%	72.89%	73.80%	-933.14%	807.30%	435.92%	113.82%	-111.25%	-91.21%	-84.25%	-58.81%	-
EPS Growth (1Y)	74.36%	62.05%	-67.45%	-135.05%	-65.08%	-79.84%	-60.50%	-142.96%	-63.51%	-28.77%	36.79%	-
Calculated Values
Free Cash Flow TTM	-86.30M	-84.04M	-77.27M	-65.73M	-47.70M	-39.25M	-28.14M	19.04M	10.69M	1.87M	-11.94M	-60.78M
Net Debt	-31.65M	-35.56M	-30.73M	-35.24M	-70.38M	-98.51M	29.07M	-78.27M	-87.09M	-4.66M	-8.47M	-18.47M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2024-08-21Purchase

Owner: Kulkarni, Sandeep Chidamb…

Title: CEO

Shares: 1,779

Price/Share: $14.85

Value: $26,418.15

Shares Owned: 7,000

Relationship: Director,Officer

Ownership: Indirect

2024-08-16Purchase

Owner: Kulkarni, Sandeep Chidamb…

Title: CEO

Shares: 5,221

Price/Share: $13.79

Value: $71,997.59

Shares Owned: 5,221

Relationship: Director,Officer

Ownership: Indirect

2024-01-29Purchase

Owner: Mcdade, Mark

Title: -

Shares: 100,000

Price/Share: $32.50

Value: $3,250,000.00

Shares Owned: 448,431

Relationship: Director

Ownership: Indirect

2023-11-17Purchase

Owner: Thiara, Parvinder

Title: -

Shares: 1,000

Price/Share: $17.31

Value: $17,310.00

Shares Owned: 83,782

Relationship: Director

Ownership: Direct

2023-11-17Purchase

Owner: Kulkarni, Sandeep Chidamb…

Title: CEO

Shares: 4,000

Price/Share: $16.99

Value: $67,960.00

Shares Owned: 729,735

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2024-08-21	Kulkarni, Sandeep Chidamb…	Director,Officer	CEO	Indirect	Purchase	1,779	14.85	$26,418.15	7,000	4
2024-08-16	Kulkarni, Sandeep Chidamb…	Director,Officer	CEO	Indirect	Purchase	5,221	13.79	$71,997.59	5,221	4
2024-01-29	Mcdade, Mark	Director	-	Indirect	Purchase	100,000	32.50	$3,250,000.00	448,431	4
2023-11-17	Thiara, Parvinder	Director	-	Direct	Purchase	1,000	17.31	$17,310.00	83,782	4
2023-11-17	Kulkarni, Sandeep Chidamb…	Director,Officer	CEO	Direct	Purchase	4,000	16.99	$67,960.00	729,735	4
2023-10-27	Castelein, Caley	Director	-	Direct	Purchase	15,800	14.55	$229,890.00	516,519	4
2023-10-26	Kulkarni, Sandeep Chidamb…	Director,Officer	CEO	Direct	Purchase	5,000	12.25	$61,250.00	725,735	4
2023-10-25	Thiara, Parvinder	Director	-	Direct	Purchase	2,000	12.12	$24,240.00	82,782	4
2023-10-24	Kantoff, Aaron	Director	-	Direct	Purchase	7,500	11.86	$88,950.00	45,391	4
2023-06-14	Ildstad, Suzanne	Director	-	Direct	Sale	12,942	2.49	$32,225.58	3,771,392	4
2023-06-09	Ildstad, Suzanne	Director	-	Direct	Sale	25,419	2.46	$62,530.74	3,815,412	4
2023-06-06	Ildstad, Suzanne	Director	-	Direct	Sale	25,549	2.53	$64,638.97	2,756,474	4
2023-06-02	Ildstad, Suzanne	Director	-	Direct	Sale	15,818	2.50	$39,545.00	2,789,864	4
2023-04-21	Ildstad, Suzanne	Director	-	Direct	Sale	15,004	2.35	$35,259.40	2,821,395	4
2023-04-20	Ildstad, Suzanne	Director	-	Direct	Sale	46,990	2.33	$109,486.70	2,836,399	4
2023-04-18	Ildstad, Suzanne	Director	-	Direct	Sale	49,211	2.15	$105,803.65	2,905,142	4
2023-03-17	Ildstad, Suzanne	Director	-	Direct	Sale	10,436	2.06	$21,498.16	3,054,124	4
2023-03-17	Ildstad, Suzanne	Director	-	Direct	Sale	10,436	2.06	$21,498.16	3,054,124	4/A
2023-03-03	Ildstad, Suzanne	Director	-	Direct	Sale	6,806	2.06	$14,020.36	3,064,560	4
2023-03-03	Ildstad, Suzanne	Director	-	Direct	Sale	6,806	2.06	$14,020.36	3,064,560	4/A
2023-03-01	Ildstad, Suzanne	Director	-	Direct	Sale	29	2.05	$59.45	3,071,366	4
2023-03-01	Ildstad, Suzanne	Director	-	Direct	Sale	29	2.05	$59.45	3,071,366	4/A
2023-02-21	Ildstad, Suzanne	Director	-	Direct	Sale	3,500	2.05	$7,175.00	3,071,395	4/A
2023-02-21	Ildstad, Suzanne	Director	-	Direct	Sale	3,500	2.05	$7,175.00	3,071,395	4
2023-02-17	Ildstad, Suzanne	Director	-	Direct	Sale	3,612	2.05	$7,404.60	3,074,895	4/A
2023-02-17	Ildstad, Suzanne	Director	-	Direct	Sale	3,612	2.05	$7,404.60	3,074,895	4
2022-08-22	Ildstad, Suzanne	Officer	Chief Scientific Officer	Direct	Sale	525,000	2.80	$1,470,000.00	3,081,446	4
2022-07-29	Requadt, Scott	Director,Officer	Chief Executive Officer	Direct	Purchase	39,382	4.25	$167,373.50	508,680	4
2022-07-28	Requadt, Scott	Director,Officer	Chief Executive Officer	Direct	Purchase	3,090	4.25	$13,132.50	469,298	4
2022-07-22	Requadt, Scott	Director,Officer	Chief Executive Officer	Direct	Purchase	9,444	3.75	$35,415.00	460,680	4
2022-07-21	Nader, Francois	Director	-	Direct	Purchase	36,500	3.72	$135,780.00	138,500	4/A
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2025-09-30

83.09%

Inst. Shares: 21,398,842

Shares Outstanding: 25,755,000

2025-06-30

92.84%

Inst. Shares: 23,910,268

Shares Outstanding: 25,755,000

2025-03-31

89.36%

Inst. Shares: 22,958,939

Shares Outstanding: 25,692,000

2024-12-31

89.74%

Inst. Shares: 22,748,472

Shares Outstanding: 25,348,000

2024-09-30

81.25%

Inst. Shares: 20,936,962

Shares Outstanding: 25,767,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2025-09-30	21,398,842	25,755,000	83.09%
2025-06-30	23,910,268	25,755,000	92.84%
2025-03-31	22,958,939	25,692,000	89.36%
2024-12-31	22,748,472	25,348,000	89.74%
2024-09-30	20,936,962	25,767,000	81.25%
2024-06-30	21,064,994	25,724,000	81.89%
2024-03-31	20,420,198	24,082,000	84.79%
2023-12-31	12,873,555	4,747,000	271.19%
2023-09-30	26,313,676	1,084,000	-
2023-06-30	24,828,921	990,000	-
2023-03-31	24,696,459	906,000	-
2022-12-31	23,232,360	877,000	-
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Tourmaline Bio, Inc. (TRML) — SEC Financial Statements & Analysis

Tourmaline Bio, Inc. (TRML) is a biological products, (no diagnostic substances) company, incorporated in DE. Tourmaline Bio, Inc. trades on None as: TRML. Based on its latest SEC filing (Form 10-Q, period ending 2025-06-30), Tourmaline Bio, Inc. reported a Debt-to-Equity ratio of 0.04x. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.04x

Data as of 2025-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Tourmaline Bio, Inc. in?

Tourmaline Bio, Inc. (TRML) operates in the Biological Products, (No Diagnostic Substances) industry.

What exchange does TRML trade on?

Tourmaline Bio, Inc. (TRML) trades on the None.

Where is Tourmaline Bio, Inc. incorporated?

Tourmaline Bio, Inc. is incorporated in DE.